BCAS1 antibody (N-Term)
Quick Overview for BCAS1 antibody (N-Term) (ABIN950616)
Target
See all BCAS1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 1-30, N-Term
-
Specificity
- This antibody reacts to BCAS1.
-
Cross-Reactivity (Details)
- Species reactivity (tested):Human.
-
Purification
- Affinity chromatography on Protein A
-
Immunogen
- KLH conjugated synthetic peptide between 1-30 amino acids from the N-terminal region of human BCAS1
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) sodium azide as preservative
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- BCAS1 (Breast Carcinoma Amplified Sequence 1 (BCAS1))
-
Alternative Name
- BCAS1 / NABC1
-
Background
- This gene resides in a region at 20q13 which is amplified in a variety of tumor types and associated with more aggressive tumor phenotypes. Among the genes identified from this region, it was found to be highly expressed in three amplified breast cancer cell lines and in one breast tumor without amplification at 20q13.2. However, this gene is not in the common region of maximal amplification and its expression was not detected in the breast cancer cell line MCF7, in which this region is highly amplified. Although not consistently expressed, this gene is a candidate oncogene.Synonyms: AIBC1, Breast carcinoma-amplified sequence 1
-
Gene ID
- 8537
-
NCBI Accession
- NP_003648
Target
-